Skip to main content
SpringerLink
Log in
Book cover

Autoimmune Diseases in Endocrinology pp 95–116Cite as

Thyroid Autoantigens

  • Chapter

  • 1374 Accesses

Part of the book series: Contemporary Endocrinology ((COE))

Summary

Identification and characterization of key antigenic targets is an important step in understanding the development and pathogenic mechanisms of autoimmune disease. Fifty years after the initial description of thyroid autoimmunity and identification of the major autoantigens, the disease remains the best understood form of human organ-specific autoimmunity. The structure and function of the major thyroid antigens, together with recent advances in our understanding of the corresponding autoimmune responses to these targets, will be discussed in this chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA. Spectrum of thyroid disease in a community – Whickham survey. Clinical Endocrinology 1977;7:481–493.

    PubMed  CAS  Google Scholar 

  2. Weetman AP, McGregor AM. Autoimmune thyroiditis: further developments in our understanding. Endocrine Reviews 1994;15:788–830.

    Article  PubMed  CAS  Google Scholar 

  3. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocrine Reviews 2003;24:802–835.

    Article  PubMed  CAS  Google Scholar 

  4. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish twin cohorts. The Journal of Clinical Endocrinology and Metabolism 2001;86:930–934.

    Article  PubMed  CAS  Google Scholar 

  5. Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. The Journal of Clinical Endocrinology and Metabolism 2000;85:536–539.

    Article  PubMed  CAS  Google Scholar 

  6. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocrine Reviews 2003;24:694–717.

    Article  PubMed  CAS  Google Scholar 

  7. van de Graaf SAR, Ris-Stalpers C, Pauws E, Mendive FM, Targovnik HM, de Vijlder JJM. Structure update – up to date with human thyroglobulin. The Journal of Endocrinology 2001;170: 307–321.

    Article  PubMed  Google Scholar 

  8. Malthiery Y, Lissitzky S. Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary-DNA. European Journal of Biochemistry 1987;165:491–498.

    Article  PubMed  CAS  Google Scholar 

  9. Malthiery Y, Marriq C, Bèrge-Lefranc JL, Franc JL, Henry M, Lejeune PJ, Ruf J, Lissitzky S. Thyroglobulin structure and function – recent advances. Biochimie 1989;71:195–210.

    Article  PubMed  CAS  Google Scholar 

  10. Geen J, Howells RC, Ludgate M, Hullin DA, Hogg SI. The prevalence of anti-acetylcholinesterase antibodies in autoimmune disease. Autoimmunity 2004;37:579–585.

    Article  PubMed  CAS  Google Scholar 

  11. Carayanniotis G. The cryptic self in thyroid autoimmunity: The paradigm of thyroglobulin. Autoimmunity 2003;36:423–428.

    Article  PubMed  CAS  Google Scholar 

  12. Kriss JP, Pleshako V, Rosenblu A, Holderne M, Sharp G, Utiger R. Studies on pathogenesis of ophthalmopathy of Graves’ disease. The Journal of Clinical Endocrinology and Metabolism 1967;27:582–593.

    PubMed  CAS  Google Scholar 

  13. Lisi S, Botta R, Agretti P, Sellari-Franceschini S, Marcocci C, Pinchera A, Marino M. Poorly specific binding of thyroglobulin to orbital fibroblasts from patients with Graves’ ophthalmopathy. Journal of Endocrinological Investigation 2005;28:420–424.

    PubMed  CAS  Google Scholar 

  14. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q133 and Hashimoto’s thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Human Molecular Genetics 2001;10:1379–1386.

    Article  PubMed  CAS  Google Scholar 

  15. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. The Journal of Clinical Endocrinology and Metabolism 2002;87:404–407.

    Article  PubMed  CAS  Google Scholar 

  16. Collins JE, Heward JM, Carr-Smith J, Daykin J, Franklyn JA, Gough SCL. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. The Journal of Clinical Endocrinology and Metabolism 2003;88:5039–5042.

    Article  PubMed  CAS  Google Scholar 

  17. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proceedings of the National Academy of Sciences of the United States of America 2003;100:15119–15124.

    Article  PubMed  CAS  Google Scholar 

  18. Collins JE, Heward JM, Howson JMM, Foxall H, Carr-Smith J, Franklyn JA, Gough SCL. Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. The Journal of Clinical Endocrinology and Metabolism 2004;89:6336–6339.

    Article  PubMed  CAS  Google Scholar 

  19. Gentile F, Conte M, Formisano S. Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure? Immunology 2004;112:13–25.

    Article  PubMed  CAS  Google Scholar 

  20. Tomer Y. Anti-thyrogloblin autoantibodies in autoimmune thyroid disease: cross reactive or pathogenic? Clinical Immunology and Immunopathology 1997;82:3–11.

    Article  PubMed  CAS  Google Scholar 

  21. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Current Opinion in Immunology 1995;7:812–818.

    Article  PubMed  CAS  Google Scholar 

  22. Yativ N, Buskila D, Blank M, Burek CL, Rose NR, Shoenfeld Y. The detection of antithyroglobulin activity in human serum monoclonal immunoglobulins (monoclonal gammopathies). Immunological Research 1993;12:330–337.

    CAS  Google Scholar 

  23. McIntosh R, Watson P, Weetman A. Somatic hypermutation in autoimmune thyroid disease. Immunological Reviews 1998;162:219–231.

    Article  PubMed  CAS  Google Scholar 

  24. Belyavin G, Trotter WR. Immunological reactions in thyroid disease. Lancet 1959;1:784–784.

    Article  Google Scholar 

  25. Bogner U, Schleusener H, Wall JR. Antibody-dependent cell-mediated cytotoxicity against human thyroid cells in Hashimoto’s thyroiditis but not Graves’ disease. The Journal of Clinical Endocrinology and Metabolism 1984;59:734–738.

    PubMed  CAS  Google Scholar 

  26. Dong Q, Ludgate M, Vassart G. Towards an antigenic map of human thyroglobulin – identification of 10 epitope-bearing sequences within the primary structure of thyroglobulin. The Journal of Endocrinology 1989;122:169–176.

    PubMed  CAS  Google Scholar 

  27. Shimojo N, Saito K, Kohno Y, Sasaki N, Tarutani O, Nakajima H. Antigenic determinants on thyroglobulin – comparison of the reactivities of different thyroglobulin preparations with serum antibodies and T-cells of patients with chronic thyroiditis. The Journal of Clinical Endocrinology and Metabolism 1988;66:689–695.

    PubMed  CAS  Google Scholar 

  28. Latrofa F, Phillips M, Rapoport B, McLachlan SM. Human monoclonal thyroglobulin autoantibodies: Epitopes and immunoglobulin genes. The Journal of Clinical Endocrinology and Metabolism 2004;89:5116–5123.

    Article  PubMed  CAS  Google Scholar 

  29. Prentice L, Kiso Y, Fukuma N, Horimoto M, Petersen V, Grennan F, Pegg C, Furmaniak J, Smith BR. Monoclonal thyroglobulin autoantibodies – variable region analysis and epitope recognition. The Journal of Clinical Endocrinology and Metabolism 1995;80:977–986.

    Article  PubMed  CAS  Google Scholar 

  30. Ruf J, Carayon P. Structural and functional aspects of thyroid peroxidase. Archives of Biochemistry and Biophysics 2006;445:269–277.

    Article  PubMed  CAS  Google Scholar 

  31. Libert F, Ruel J, Ludgate M, Swillens S, Alexander N, Vassart G, Dinsart C. Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules. The EMBO Journal 1987;6:4193–4196.

    PubMed  CAS  Google Scholar 

  32. Magnusson RP, Chazenbalk GD, Gestautas J, Seto P, Filetti S, Degroot LJ, Rapoport B. Molecular-cloning of the complementary deoxyribonucleic-acid for human thyroid peroxidase. Molecular Endocrinology 1987;1:856–861.

    PubMed  CAS  Google Scholar 

  33. Kimura S, Kotani T, McBride OW, Umeki K, Hirai K, Nakayama T, Ohtaki S. Human thyroid peroxidase – complete cDNA and protein-sequence, chromosome mapping, and identification of 2 alternately spliced messenger-RNAs. Proceedings of the National Academy of Sciences of the United States of America 1987;84:5555–5559.

    Article  PubMed  CAS  Google Scholar 

  34. Libert F, Ruel J, Ludgate M, Swillens S, Alexander N, Vassart G, Dinsart C. Complete nucleotide-sequence of the human thyroperoxidase-microsomal antigen cDNA. Nucleic Acids Research 1987;15:6735–6735.

    Article  PubMed  CAS  Google Scholar 

  35. Devijlder JJM, Dinsart C, Libert F, Vankessel AG, Bikker H, Bolhuis PA, Vassart G. Regional localization of the gene for thyroid peroxidase to human-chromosome 2pter-P12. Cytogenetics and Cell Genetics 1988;47:170–172.

    Article  CAS  Google Scholar 

  36. Taylor JC, Gough SC, Hunt PJ, Brix TH, Chatterjee K, Connell JM, Franklyn JA, Hegedus L, Robinson BG, Wiersinga WM, Wass JAH, Zabaneh D, Mackay I, Weetman AP. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. The Journal of Clinical Endocrinology and Metabolism 2006;91:646–653.

    Article  PubMed  CAS  Google Scholar 

  37. Wick G, Most J, Schauenstein K, Kromer G, Dietrich H, Ziemiecki A, Fassler R, Schwarz S, Neu N, Hala K. Spontaneous autoimmune-thyroiditis – a birds eye-view. Immunology Today 1985;6:359–364.

    Article  Google Scholar 

  38. Allen EM, Appel MC, Braverman LE. The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Endocrinology 1986;118:1977–1981.

    PubMed  CAS  Google Scholar 

  39. Rasooly L, Burek CL, Rose NR. Iodine-induced autoimmune thyroiditis in NOD-H-2(h4) mice. Clinical Immunology and Immunopathology 1996;81:287–292.

    Article  PubMed  CAS  Google Scholar 

  40. Dayan CM, Londei M, Corcoran AE, Grubeck-Loebenstein B, James RFL, Rapoport B, Feldmann M. Autoantigen recognition by thyroid-infiltrating T-cells in Graves-disease. Proceedings of the National Academy of Sciences of the United States of America 1991;88:7415–7419.

    Article  PubMed  CAS  Google Scholar 

  41. Fisfalen ME, Palmer EM, van Seventer GA, Soltani K, Sawai Y, Kaplan E, Hidaka Y, Ober C, DeGroot LJ. Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. Clinical and Experimental Immunology 1997;82: 3655–3663.

    CAS  Google Scholar 

  42. Fisfalen ME, Soliman M, Okamoto Y, Soltani K, DeGroot LJ. Proliferative responses of T-cells to thyroid antigens and synthetic thyroid peroxidase peptides in autoimmune thyroid-disease. The Journal of Clinical Endocrinology and Metabolism 1995;80:1597–1604.

    Article  PubMed  CAS  Google Scholar 

  43. Kawakami Y, Fisfalen ME, DeGroot LJ. Proliferative responses of peripheral blood mononuclear cells from patients with autoimmune thyroid disease to synthetic peptide epitopes of human thyroid peroxidase. Autoimmunity 1992;13:17–26.

    Article  PubMed  CAS  Google Scholar 

  44. Tandon N, Freeman M, Weetman AP. T cell responses to synthetic thyroid peroxidase peptides in autoimmune thyroid disease. Clinical and Experimental Immunology 1991;86:56–60.

    Article  PubMed  CAS  Google Scholar 

  45. Fukuma N, McLachlan SM, Rapoport B, Goodacre J, Middleton SL, Philips DIW, Pegg CAS, Rees Smith B. Thyroid autoantigens and human T cell responses. Clinical and Experimental Immunology 1990;82:275–283.

    Article  PubMed  CAS  Google Scholar 

  46. Quaratino S, Thorpe CJ, Travers PJ, Londei M. Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proceedings of the National Academy of Science United States of America 1995;92:10398–10402.

    Article  CAS  Google Scholar 

  47. McLachlan SM, Rapoport B. Evidence for a potential common T-cell epitope between human thyroid peroxidase and human thyroglobulin with implications for the pathogenesis of autoimmune thyroid-disease. Autoimmunity 1989;5:101–106.

    Article  PubMed  CAS  Google Scholar 

  48. Hoshioka A, Kohno Y, Katsuki T, Shimojo N, Maruyama N, Inagaki Y, Yokochi T, Tarutani O, Hosoya T, Niimi H. A common T-cell epitope between human thyroglobulin and human thyroid peroxidase is related to murine experimental autoimmune-thyroiditis. Immunology Letters 1993;37:235–239.

    Article  PubMed  CAS  Google Scholar 

  49. Quaratino S, Badami E, Pang YY, Bartok I, Dyson J, Kioussis D, Londei M, Maiuri L. Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nature Medicine 2004;10:920–926.

    Article  PubMed  CAS  Google Scholar 

  50. Guo J, Pichurin PN, Morris JC, Rapoport B, McLachlan SM. “Naked” deoxyribonucleic acid vaccination induces recognition of diverse thyroid peroxidase T cell epitopes. Endocrinology 2004;145:3671–3678.

    Article  PubMed  CAS  Google Scholar 

  51. Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid-diseases. FEBS Letters 1985;190:147–152.

    Article  PubMed  CAS  Google Scholar 

  52. Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A. Antithyroid peroxidase autoantibodies in thyroid-diseases. The Journal of Clinical Endocrinology and Metabolism 1990;71:661–669.

    PubMed  CAS  Google Scholar 

  53. Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune-thyroiditis. The Journal of Clinical Endocrinology and Metabolism 1993;77:1700–1705.

    Article  PubMed  CAS  Google Scholar 

  54. McLachlan SM, Atherton MC, Pegg CAS, Young ET, Clark F, Smith BR. Mechanisms of thyroid destruction in autoimmune thyroid-disease. The Journal of Endocrinology 1987;112:285–285.

    Google Scholar 

  55. Libert F, Ludgate M, Dinsart C, Vassart G. Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector. The Journal of Clinical Endocrinology and Metabolism 1991;73:857–860.

    PubMed  CAS  Google Scholar 

  56. Finke R, Seto P, Ruf J, Carayon P, Rapoport B. Determination at the molecular-level of a B-cell epitope on thyroid peroxidase likely to be associated with autoimmune thyroid-disease. The Journal of Clinical Endocrinology and Metabolism 1991;73:919–921.

    Article  PubMed  CAS  Google Scholar 

  57. Bresson D, Cerutti M, Devauchelle G, Pugniere M, Roquet F, Bes C, Bossard C, Chardes T, Peraldi-Roux S. Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. The Journal of Biological Chemistry 2003;278:9560–9569.

    Article  PubMed  CAS  Google Scholar 

  58. Ruf J, Toubert ME, Czarnocka B, Durandgorde JM, Ferrand M, Carayon P. Relationship between immunological structure and biochemical-properties of human thyroid peroxidase. Endocrinology 1989;125:1211–1218.

    PubMed  CAS  Google Scholar 

  59. McLachlan SM, Rapoport B. Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies – markers of the human thyroid autoimmune-response. Clinical and Experimental Immunology 1995;101:200–206.

    PubMed  CAS  Google Scholar 

  60. Chazenbalk GD, Costante G, Portolano S, McLachlan SM, Rapoport B. The immunodominant region on human thyroid peroxidase recognized by autoantibodies does not contain the monoclonal-antibody 47/C21 linear epitope. The Journal of Clinical Endocrinology and Metabolism 1993;77:1715–1718.

    Article  PubMed  CAS  Google Scholar 

  61. Zeng J, Fenna RE. X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. Journal of Molecular Biology 1992;226:185–207.

    Article  PubMed  CAS  Google Scholar 

  62. Nishikawa T, Nagayama Y, Seto P, Rapoport B. Human thyroid peroxidase-myeloperoxidase chimeric molecules – tools for the study of antigen recognition by thyroid peroxidase autoantibodies. Endocrinology 1993;133:2496–2501.

    Article  PubMed  CAS  Google Scholar 

  63. Nishikawa T, Rapoport B, McLachlan SM. The quest for the autoantibody immunodominant region on thyroid peroxidase: Guided mutagenesis based on a hypothetical three-dimensional model. Endocrinology 1996;137:1000–1006.

    Article  PubMed  CAS  Google Scholar 

  64. Hobby P, Gardas A, Radomski R, McGregor AM, Banga JP, Sutton BJ. Identification of an immunodominant region recognized by human autoantibodies in a three-dimensional model of thyroid peroxidase. Endocrinology 2000;141:2018–2026.

    Article  PubMed  CAS  Google Scholar 

  65. Guo J, McIntosh RS, Czarnocka B, Weetman AP, Rapoport B, McLachlan SM. Relationship between autoantibody epitopic recognition and immunoglobulin gene usage. Clinical and Experimental Immunology 1998;111:408–414.

    Article  PubMed  CAS  Google Scholar 

  66. Jones FG, Ziemnicka K, Sanders J, Wolstenholme A, Fiera R, Furmaniak J, Smith BR. Analysis of autoantibody epitopes on human thyroid peroxidase. Autoimmunity 1999;30:157–169.

    Article  CAS  Google Scholar 

  67. Guo J, Yan XM, McLachlan SM, Rapoport B. Search for the autoantibody immunodominant region on thyroid peroxidase: epitopic footprinting with a human monoclonal autoantibody locates a facet on the native antigen containing a highly conformational epitope. Journal of Immunology 2001;166:1327–1333.

    CAS  Google Scholar 

  68. Bresson D, Pugniere M, Roquet F, Rebuffat SA, N-Guyen B, Cerutti M, Guo J, McLachlan SM, Rapoport B, Estienne V, Ruf J, Chardes T, Peraldi-Roux S. Directed mutagenesis in region 713–720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies. The Journal of Biological Chemistry 2004;279:39058–39067.

    Article  PubMed  CAS  Google Scholar 

  69. Gora M, Gardas A, Watson PF, Hobby P, Weetman AP, Sutton BJ, Banga JP. Key residues contributing to dominant conformational autoantigenic epitopes on thyroid peroxidase identified by mutagenesis. Biochemical and Biophysical Research Communications 2004;320:795–801.

    Article  PubMed  CAS  Google Scholar 

  70. Tonacchera M, Van Sande J, Parma J, Duprez L, Cetani F, Costagliola S, Dumont JE, Vassart G. TSH receptor and disease. Clinical Endocrinology 1996;44:621–633.

    Article  PubMed  CAS  Google Scholar 

  71. Szkudlinski MW, Fremont V, Ronin C, Weintraub BD. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiological Reviews 2002;82:473–502.

    PubMed  CAS  Google Scholar 

  72. Fan QR, Hendrickson WA. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 2005;433:269–277.

    Article  PubMed  CAS  Google Scholar 

  73. Kobe B, Deisenhofer J. The leucine-rich repeat – a versatile binding motif. Trends in Biochemical Sciences 1994;19:415–421.

    Article  PubMed  CAS  Google Scholar 

  74. Kobe B, Deisenhofer J. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. Journal of Molecular Biology 1996;264:1028–1043.

    Article  PubMed  CAS  Google Scholar 

  75. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocrine Reviews 1998;19:673–716.

    Article  PubMed  CAS  Google Scholar 

  76. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Molecular Endocrinology 2002;16:736–746.

    Article  PubMed  CAS  Google Scholar 

  77. Baker G, Mazziotti G, von Ruhland C, Ludgate M. Reevaluating thyrotropin receptor-induced mouse models of Graves’ disease and ophthalmopathy. Endocrinology 2005;146:835–844.

    Article  PubMed  CAS  Google Scholar 

  78. Parmentier M, Libert F, Maenhaut C, Lefort A, Gerard C, Perret J, Vansande J, Dumont JE, Vassart G. Molecular-cloning of the thyrotropin receptor. Science 1989;246:1620–1622.

    Article  PubMed  CAS  Google Scholar 

  79. Nagayama Y, Kaufman KD, Seto P, Rapoport B. Molecular-cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochemical and Biophysical Research Communications 1989;165:1184–1190.

    Article  PubMed  CAS  Google Scholar 

  80. Misrahi M, Loosfelt H, Atger M, Sar S, Guiochonmantel A, Milgrom E. Cloning, sequencing and expression of human TSH receptor. Biochemical and Biophysical Research Communications 1990;166:394–403.

    Article  PubMed  CAS  Google Scholar 

  81. Rousseaumerck MF, Misrahi M, Loosfelt H, Atger M, Milgrom E, Berger R. Assignment of the human thyroid stimulating hormone receptor (TSHR) gene to chromosome-14q31. Genomics 1990;8:233–236.

    Article  CAS  Google Scholar 

  82. Gross B, Misrahi M, Sar S, Milgrom E. Composite structure of the human thyrotropin receptor gene. Biochemical and Biophysical Research Communications 1991;177:679–687.

    Article  PubMed  CAS  Google Scholar 

  83. Bahn RS, Dutton CM, Heufelder AE, Sarkar G. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves ophthalmopathy. The Journal of Clinical Endocrinology and Metabolism 1994;78:256–260.

    Article  PubMed  CAS  Google Scholar 

  84. Cuddihy RM, Dutton CM, Bahn RS. A polymorphism in the extracellular domain of the thyrotropin receptor Is highly associated with autoimmune thyroid-disease in females. Thyroid 1995;5:89–95.

    PubMed  CAS  Google Scholar 

  85. Watson PF, French A, Pickerill AP, McIntosh RS, Weetman AP. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves-disease. The Journal of Clinical Endocrinology and Metabolism 1995;80:1032–1035.

    Article  PubMed  CAS  Google Scholar 

  86. Kotsa KD, Watson PF, Weetman AP. No association between a thyrotropin receptor gene polymorphism and Graves’ disease in the female population. Thyroid 1997;7:31–33.

    PubMed  CAS  Google Scholar 

  87. deRoux N, Shields DC, Misrahi M, Ratanachaiyavong S, McGregor AM, Milgrom E. Analysis of the thyrotropin receptor as a candidate gene in familial Graves’ disease. The Journal of Clinical Endocrinology and Metabolism 1996;81:3483–3486.

    Article  CAS  Google Scholar 

  88. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. Mapping the major susceptibility loci for familial Graves’ and Hashimoto’s diseases: Evidence for genetic heterogeneity and gene interactions. The Journal of Clinical Endocrinology and Metabolism 1999;84:4656–4664.

    Article  PubMed  CAS  Google Scholar 

  89. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y, Akamizu T. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves’ disease. The Journal of Clinical Endocrinology and Metabolism 2005;90:2898–2903.

    Article  PubMed  CAS  Google Scholar 

  90. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, Mackay I, Franklyn JA, Connell JM, Wass JA, Wiersinga WM, Hegedus L, Brix T, Robinson BG, Hunt PJ, Weetman AP, Carey AH, Gough SC. Association of the TSHR gene with Graves’ disease: the first disease specific locus. European Journal of Human Genetics 2005;13:1223–1230.

    Article  PubMed  CAS  Google Scholar 

  91. Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TF. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves’ disease. The Journal of Clinical Endocrinology and Metabolism 1997;82:3361–3366.

    Article  PubMed  CAS  Google Scholar 

  92. Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proceedings of the National Academy of Sciences of the United States of America 2002;99:15776–15781.

    Article  PubMed  CAS  Google Scholar 

  93. Pichurin PN, Pichurina O, Marians RC, Chen CR, Davies TF, Rapoport B, McLachlan SM. Thyrotropin receptor knockout mice: Studies on immunological tolerance to a major thyroid autoantigen. Endocrinology 2004;145:1294–1301.

    Article  PubMed  CAS  Google Scholar 

  94. Coles AJ, Wing N, Smith S, Coraddu F, Greer S, Taylor C, Weetman A, Hale G, Chatterjee VK, Waldmann H, Compston A. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999;354:1691–1695.

    Article  PubMed  CAS  Google Scholar 

  95. Chen F, Day SL, Metcalfe RA, Sethi G, Kapembwa MS, Brook MG, Churchill D, de Ruiter A, Robinson S, Lacey CJ, Weetman AP. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine 2005;84:98–106.

    Article  PubMed  CAS  Google Scholar 

  96. Volpe R. Suppressor T-lymphocyte dysfunction is important in the pathogenesis of autoimmune thyroid-disease – a perspective. Thyroid 1993;3:345–352.

    PubMed  CAS  Google Scholar 

  97. Chiovato L, Vitti P, Bendinelli G, Santini F, Fiore E, Capaccioli A, Tonacchera M, Mammoli C, Ludgate M, Pinchera A. Detection of antibodies blocking thyrotropin effect using chinese-hamster ovary cells transfected with the cloned human TSH receptor. Journal of Endocrinological Investigation 1994;17:809–816.

    PubMed  CAS  Google Scholar 

  98. Sanders J, Evans M, Premawardhana L, Depraetere H, Jeffreys J, Richards T, Furmaniak J, Smith BR. Human monoclonal thyroid stimulating autoantibody. Lancet 2003;362:126–128.

    Article  PubMed  CAS  Google Scholar 

  99. Morgenthaler NG. New assay systems for thyrotropin receptor antibodies. Current Opinion in Endocrinology and Diabetes 1999;6:251–260.

    Article  CAS  Google Scholar 

  100. Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, Williams RC, Shine B, Marshall NJ. Thyroid-stimulating antibody-activity between different immunoglobulin-G subclasses. The Journal of Clinical Investigation 1990;86:723–727.

    PubMed  CAS  Google Scholar 

  101. Shimojo N, Kohno Y, Yamaguchi K, Kikuoka S, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proceedings of the National Academy of Sciences of the United States of America 1996;93:11074–11079.

    Article  PubMed  CAS  Google Scholar 

  102. Ando T, Imaizumi M, Graves P, Unger P, Davies TF. Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters. Endocrinology 2003;144:671–680.

    Article  PubMed  CAS  Google Scholar 

  103. Costagliola S, Many MC, Denef JF, Pohlenz J, Refetoff S, Vassart G. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves’ disease. The Journal of Clinical Investigation 2000;105:803–811.

    PubMed  CAS  Google Scholar 

  104. Nagayama Y. Animal models of Graves’ hyperthyroidism. Endocrine Journal 2005;52:385–394.

    Article  PubMed  CAS  Google Scholar 

  105. McLachlan SM, Rapoport B. Thyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forward. Clinical Endocrinology 2004;61:10–18.

    Article  PubMed  CAS  Google Scholar 

  106. McLachlan SM, Nagayama Y, Rapoport B. Insight into Graves’ hyperthyroidism from animal models. Endocrine Reviews 2005;26:800–832.

    Article  PubMed  CAS  Google Scholar 

  107. Chen CR, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM. The thyrotropin receptor autoantigen in Graves’ disease is the culprit as well as the victim. The Journal of Clinical Investigation 2003;111:1897–1904.

    Article  PubMed  CAS  Google Scholar 

  108. Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF. A monoclonal thyroid-stimulating antibody. The Journal of Clinical Investigation 2002;110:1667–1674.

    Article  PubMed  CAS  Google Scholar 

  109. Costagliola S, Franssen JDF, Bonomi M, Urizar E, Willnich M, Bergmann A, Vassart G. Generation of a mouse monoclonal TSH receptor antibody with stimulating activity. Biochemical and Biophysical Research Communications 2002;299:891–896.

    Article  PubMed  CAS  Google Scholar 

  110. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak JG, Smith BR. Thyroid-stimulating monoclonal antibodies. Thyroid 2002;12:1043–1050.

    Article  PubMed  Google Scholar 

  111. McLachlan SM, Rapoport B. Monoclonal, human autoantibodies to the TSH receptor – The holy grail and why are we looking for it? The Journal of Clinical Endocrinology and Metabolism 1996;81:3152–3154.

    Article  PubMed  CAS  Google Scholar 

  112. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Reviews 2003;24:48–77.

    Article  PubMed  CAS  Google Scholar 

  113. Endo T, Kogai T, Nakazato M, Saito T, Kaneshige M, Onaya T. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease. Biochemical and Biophysical Research Communications 1996;224:92–95.

    Article  PubMed  CAS  Google Scholar 

  114. Ajjan RA, Findlay C, Metcalfe RA, Watson PF, Crisp M, Ludgate M, Weetman AP. The modulation of the human sodium iodide symporter activity by Graves’ disease sera. The Journal of Clinical Endocrinology and Metabolism 1998;83:1217–1221.

    Article  PubMed  CAS  Google Scholar 

  115. Ajjan RA, Kemp EH, Waterman EA, Watson PF, Endo T, Onaya T, Weetman AP. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease. The Journal of Clinical Endocrinology and Metabolism 2000;85:2020–2027.

    Article  PubMed  CAS  Google Scholar 

  116. Chin HS, Chin DKH, Morgenthaler NG, Vassart G, Costagliola S. Rarity of anti-Na+/I-symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD). The Journal of Clinical Endocrinology and Metabolism 2000;85:3937–3940.

    Article  PubMed  CAS  Google Scholar 

  117. Marinò M, Zheng G, McCluskey RT. Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured Fisher rat thyroid cells. The Journal of Biological Chemistry 1999;274:12898–12904.

    Article  PubMed  Google Scholar 

  118. Lisi S, Segnani C, Mattii L, Botta R, Marcocci C, Dolfi A, McCluskey RT, Pinchera A, Bernardini N, Marino M. Thyroid dysfunction in megalin deficient mice. Molecular and Cellular Endocrinology 2005;236:43–47.

    Article  PubMed  CAS  Google Scholar 

  119. Marinò M, Chiovato L, Friedlander JA, Latrofa F, Pinchera A, McCluskey RT. Serum antibodies against megalin (gp330) in patients with autoimmune thyroiditis. The Journal of Clinical Endocrinology and Metabolism 1999;84:2468–2474.

    Article  PubMed  Google Scholar 

  120. Illies F, Wingert AM, Bald M, Hoyer PF. Autoimmune thyroiditis in association with membranous nephropathy. Journal of Pediatric Endocrinology & Metabolism 2004;17:99–104.

    Google Scholar 

Download references

Authors
  1. Philip F. Watson Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nagat Saeed Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Anthony P. Weetman MD,DSc

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this chapter

Cite this chapter

Watson, P.F., Saeed, N. (2007). Thyroid Autoantigens. In: Weetman, A.P. (eds) Autoimmune Diseases in Endocrinology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-517-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-517-6_5

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-733-4

  • Online ISBN: 978-1-59745-517-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation